218 related articles for article (PubMed ID: 17719542)
1. hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes.
Tanaka T; Ohkubo S; Tatsuno I; Prives C
Cell; 2007 Aug; 130(4):638-50. PubMed ID: 17719542
[TBL] [Abstract][Full Text] [Related]
2. Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response.
Wei X; Xu H; Kufe D
Cancer Cell; 2005 Feb; 7(2):167-78. PubMed ID: 15710329
[TBL] [Abstract][Full Text] [Related]
3. Hzf and hCAS/CSE1L: making the right choice in p53-mediated tumour suppression.
Ewings KE; Ryan KM
Cell Res; 2007 Oct; 17(10):829-31. PubMed ID: 17934491
[No Abstract] [Full Text] [Related]
4. Chromatin immunoprecipitation-on-chip reveals stress-dependent p53 occupancy in primary normal cells but not in established cell lines.
Shaked H; Shiff I; Kott-Gutkowski M; Siegfried Z; Haupt Y; Simon I
Cancer Res; 2008 Dec; 68(23):9671-7. PubMed ID: 19047144
[TBL] [Abstract][Full Text] [Related]
5. A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control, and apoptosis.
Nagashima M; Shiseki M; Pedeux RM; Okamura S; Kitahama-Shiseki M; Miura K; Yokota J; Harris CC
Oncogene; 2003 Jan; 22(3):343-50. PubMed ID: 12545155
[TBL] [Abstract][Full Text] [Related]
6. A novel mechanism for p53 to regulate its target gene ECK in signaling apoptosis.
Jin YJ; Wang J; Qiao C; Hei TK; Brandt-Rauf PW; Yin Y
Mol Cancer Res; 2006 Oct; 4(10):769-78. PubMed ID: 17050670
[TBL] [Abstract][Full Text] [Related]
7. Regulation of p53 activity through lysine methylation.
Chuikov S; Kurash JK; Wilson JR; Xiao B; Justin N; Ivanov GS; McKinney K; Tempst P; Prives C; Gamblin SJ; Barlev NA; Reinberg D
Nature; 2004 Nov; 432(7015):353-60. PubMed ID: 15525938
[TBL] [Abstract][Full Text] [Related]
8. Synergic CSE1L/CAS, TNFR-1, and p53 apoptotic pathways in combined interferon-gamma/adriamycin-induced apoptosis of Hep G2 hepatoma cells.
Jiang MC; Luo SF; Li LT; Lin CC; Du SY; Lin CY; Hsu YW; Liao CF
J Exp Clin Cancer Res; 2007 Mar; 26(1):91-9. PubMed ID: 17550137
[TBL] [Abstract][Full Text] [Related]
9. PHTS, a novel putative tumor suppressor, is involved in the transformation reversion of HeLaHF cells independently of the p53 pathway.
Yu DH; Fan W; Liu G; Nguy V; Chatterton JE; Long S; Ke N; Meyhack B; Bruengger A; Brachat A; Wong-Staal F; Li QX
Exp Cell Res; 2006 Apr; 312(6):865-76. PubMed ID: 16413018
[TBL] [Abstract][Full Text] [Related]
10. Increased cellular apoptosis susceptibility (CSE1L/CAS) protein expression promotes protrusion extension and enhances migration of MCF-7 breast cancer cells.
Tai CJ; Shen SC; Lee WR; Liao CF; Deng WP; Chiou HY; Hsieh CI; Tung JN; Chen CS; Chiou JF; Li LT; Lin CY; Hsu CH; Jiang MC
Exp Cell Res; 2010 Oct; 316(17):2969-81. PubMed ID: 20688056
[TBL] [Abstract][Full Text] [Related]
11. DNA damage signalling recruits RREB-1 to the p53 tumour suppressor promoter.
Liu H; Hew HC; Lu ZG; Yamaguchi T; Miki Y; Yoshida K
Biochem J; 2009 Aug; 422(3):543-51. PubMed ID: 19558368
[TBL] [Abstract][Full Text] [Related]
12. The tumor suppressor p53 associates with gene coding regions and co-traverses with elongating RNA polymerase II in an in vivo model.
Balakrishnan SK; Gross DS
Oncogene; 2008 Apr; 27(19):2661-72. PubMed ID: 18026140
[TBL] [Abstract][Full Text] [Related]
13. p53-mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y.
Faniello MC; Di Sanzo M; Quaresima B; Baudi F; Di Caro V; Cuda G; Morrone G; Del Sal G; Spinelli G; Venuta S; Costanzo F
Int J Biochem Cell Biol; 2008; 40(10):2110-9. PubMed ID: 18372207
[TBL] [Abstract][Full Text] [Related]
14. p53 and Delta Np63 alpha differentially bind and regulate target genes involved in cell cycle arrest, DNA repair and apoptosis.
Schavolt KL; Pietenpol JA
Oncogene; 2007 Sep; 26(42):6125-32. PubMed ID: 17404570
[TBL] [Abstract][Full Text] [Related]
15. DUSP1 is controlled by p53 during the cellular response to oxidative stress.
Liu YX; Wang J; Guo J; Wu J; Lieberman HB; Yin Y
Mol Cancer Res; 2008 Apr; 6(4):624-33. PubMed ID: 18403641
[TBL] [Abstract][Full Text] [Related]
16. In vivo analyses of UV-irradiation-induced p53 promoter binding using a novel quantitative real-time PCR assay.
Potratz JC; Mlody B; Berdel WE; Serve H; Müller-Tidow C
Int J Oncol; 2005 Feb; 26(2):493-8. PubMed ID: 15645135
[TBL] [Abstract][Full Text] [Related]
17. An integrated map of p53-binding sites and histone modification in the human ENCODE regions.
Kaneshiro K; Tsutsumi S; Tsuji S; Shirahige K; Aburatani H
Genomics; 2007 Feb; 89(2):178-88. PubMed ID: 17085012
[TBL] [Abstract][Full Text] [Related]
18. Expression of an IFN-inducible cellular senescence gene, IFI16, is up-regulated by p53.
Song LL; Alimirah F; Panchanathan R; Xin H; Choubey D
Mol Cancer Res; 2008 Nov; 6(11):1732-41. PubMed ID: 18974396
[TBL] [Abstract][Full Text] [Related]
19. A novel antioxidant function for the tumor-suppressor gene p53 in the retinal ganglion cell.
O'Connor JC; Wallace DM; O'Brien CJ; Cotter TG
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4237-44. PubMed ID: 18487368
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase activity in conjunction with E2F-1 and p53 regulates Apaf-1 expression in 661W cells and the retina.
Wallace DM; Cotter TG
J Neurosci Res; 2009 Mar; 87(4):887-905. PubMed ID: 18951482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
